This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Capricor Therapeutics, Inc.

Drug Names(s): CAP2003, CAP 2003, CDC Exosomes

Description: Capricor is developing CAP-2003 using the Company's exosomes platform technology. Although no specific details for CAP-2003 have been provided by the company, they are likely based on exosomes originating from cardiosphere-derived cells (CDCs) like other drugs in the company's pipeline.

Exosomes are natural vesicles within cells that carry RNA and protein cargo. They are believed to serve as messengers among cells and may play roles in coagulation, intercellular signaling, and waste management.

CAP-2003 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug